GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » EV-to-FCF

Kolon Life Science (XKRX:102940) EV-to-FCF : -9.99 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kolon Life Science's Enterprise Value is ₩350,802 Mil. Kolon Life Science's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-35,103 Mil. Therefore, Kolon Life Science's EV-to-FCF for today is -9.99.

The historical rank and industry rank for Kolon Life Science's EV-to-FCF or its related term are showing as below:

XKRX:102940' s EV-to-FCF Range Over the Past 10 Years
Min: -249.38   Med: -17.41   Max: 272.87
Current: -9.99

During the past 13 years, the highest EV-to-FCF of Kolon Life Science was 272.87. The lowest was -249.38. And the median was -17.41.

XKRX:102940's EV-to-FCF is ranked worse than
100% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.52 vs XKRX:102940: -9.99

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Kolon Life Science's stock price is ₩21950.00. Kolon Life Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-2683.104. Therefore, Kolon Life Science's PE Ratio for today is At Loss.


Kolon Life Science EV-to-FCF Historical Data

The historical data trend for Kolon Life Science's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science EV-to-FCF Chart

Kolon Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.17 -39.12 -25.87 -14.00 -11.21

Kolon Life Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.99 -18.18 -21.66 -11.21 -9.47

Competitive Comparison of Kolon Life Science's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Kolon Life Science's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kolon Life Science's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kolon Life Science's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Kolon Life Science's EV-to-FCF falls into.



Kolon Life Science EV-to-FCF Calculation

Kolon Life Science's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=350802.469/-35102.511
=-9.99

Kolon Life Science's current Enterprise Value is ₩350,802 Mil.
Kolon Life Science's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-35,103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kolon Life Science  (XKRX:102940) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kolon Life Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21950.00/-2683.104
=At Loss

Kolon Life Science's share price for today is ₩21950.00.
Kolon Life Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2683.104.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Kolon Life Science EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kolon Life Science (XKRX:102940) Business Description

Traded in Other Exchanges
N/A
Address
110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR
Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science (XKRX:102940) Headlines

No Headlines